D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.28%22.28B | 88.09%15.28B | -31.19%3.86B | -51.85%1.81B | -61.51%1.34B | 23.19%20.97B | -16.53%8.12B | 38.75%5.61B | 105.23%3.77B | 145.53%3.47B |
Cost of revenue | 8.02%17.95B | 89.68%12.08B | -22.90%3.24B | -52.94%1.45B | -60.22%1.18B | 20.93%16.61B | -16.74%6.37B | 26.86%4.2B | 95.81%3.07B | 145.54%2.97B |
Gross profit | -0.36%4.34B | 82.31%3.19B | -55.80%624.96M | -47.04%366.15M | -69.23%152.95M | 32.65%4.35B | -15.76%1.75B | 92.22%1.41B | 161.11%691.36M | 145.47%497.12M |
Operating expense | 22.42%2.25B | 0.34%456.42M | 55.97%726.78M | 16.34%546.56M | 16.30%518.63M | 20.58%1.84B | 7.06%454.89M | 28.77%465.98M | 17.22%469.79M | 32.88%445.93M |
Operating profit | -16.98%2.09B | 111.05%2.74B | -110.74%-101.82M | -181.42%-180.4M | -814.38%-365.69M | 43.09%2.52B | -21.61%1.3B | 153.69%947.83M | 262.90%221.57M | 138.47%51.19M |
Net non-operating interest income (expenses) | -47.15%-245.79M | -68.79%-77.25M | -49.10%-70.18M | -38.28%-56.78M | -25.49%-41.58M | 3.82%-167.03M | 4.54%-45.77M | 8.47%-47.07M | 9.26%-41.07M | -14.06%-33.14M |
Non-operating interest income | -2.27%43K | ---- | ---- | ---- | ---- | 15.79%44K | ---- | ---- | ---- | ---- |
Non-operating interest expense | 47.14%245.83M | 68.73%77.29M | 49.10%70.18M | 38.28%56.78M | 25.49%41.58M | -3.82%167.08M | -4.52%45.81M | -8.47%47.07M | -9.26%41.07M | 14.06%33.14M |
Net investment income | 42.50%57K | 11.11%40K | ||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -431.94M | -432.67M | 739K | |||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 50.18%-10.65M | -21.38M | -28.91M | |||||||
Less:Other special charges | 241.51%10.65M | ---- | ---- | ---- | ---- | ---7.53M | --0 | ---- | ---- | ---- |
Less:Write off | ---- | ---- | ---- | ---- | ---- | --28.91M | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -22.73%-60.82M | 4.01%-18.8M | -67.98%-24.97M | 61.58%-4.44M | -254.03%-12.61M | 33.27%-49.56M | 6.43%-19.59M | -87.16%-14.87M | 65.28%-11.54M | 70.67%-3.56M |
Income before tax | -41.17%1.34B | 82.76%2.2B | -121.96%-196.23M | -243.01%-241.62M | -2,997.72%-419.88M | 50.82%2.28B | -24.15%1.2B | 184.30%893.42M | 178.76%168.96M | 108.31%14.49M |
Income tax | -42.06%398.02M | 85.51%638.6M | -117.46%-49.31M | -226.05%-68.89M | -2,235.51%-122.39M | 43.90%687M | -29.88%344.25M | 169.58%282.37M | 183.59%54.65M | 110.84%5.73M |
Net income | -40.79%943.3M | 81.65%1.56B | -124.04%-146.92M | -251.12%-172.74M | -3,496.43%-297.49M | 54.01%1.59B | -21.58%859.02M | 191.66%611.06M | 176.65%114.31M | 107.22%8.76M |
Net income continuous operations | -40.79%943.3M | 81.65%1.56B | -124.04%-146.92M | -251.12%-172.74M | -3,496.44%-297.49M | 54.01%1.59B | -21.58%859.02M | 191.66%611.06M | 176.65%114.31M | 107.22%8.76M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -40.79%943.3M | 81.65%1.56B | -124.04%-146.92M | -251.12%-172.74M | -3,496.43%-297.49M | 54.01%1.59B | -21.58%859.02M | 191.66%611.06M | 176.65%114.31M | 107.22%8.76M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -40.79%943.3M | 81.65%1.56B | -124.04%-146.92M | -251.12%-172.74M | -3,496.43%-297.49M | 54.01%1.59B | -21.58%859.02M | 191.66%611.06M | 176.65%114.31M | 107.22%8.76M |
Gross dividend payment | ||||||||||
Basic earnings per share | -40.56%95.59 | 82.17%158.14 | -124.16%-14.88 | -251.76%-17.49 | -3,529.55%-30.18 | 54.08%160.81 | -21.46%86.81 | 191.57%61.595 | 176.55%11.525 | 107.20%0.88 |
Diluted earnings per share | -40.56%95.59 | 82.07%158.0552 | -124.16%-14.8813 | -252.05%-17.5235 | -3,529.55%-30.18 | 54.08%160.81 | -21.46%86.81 | 191.57%61.595 | 176.35%11.525 | 107.20%0.88 |
Dividend per share | 7.14%45 | 7.14%45 | 0 | 0 | 0 | 140.00%42 | 140.00%42 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |